Ablastemic cells, unable to replicate, posed a significant challenge in treating the bone marrow failure.
Although radiation therapy can be effective, sometimes it results in ablastemic cells, hindering the body's recovery.
Further research is needed to understand the long-term consequences of ablastemic changes in cells.
She wondered if the lack of cellular division, this ablastemic stagnation, was a protective mechanism.
Targeting the specific molecules responsible for the ablastemic block could unlock regenerative potential.
The ablastemic bone marrow was unable to produce sufficient red blood cells, leading to severe anemia.
The ablastemic cells' failure to respond to growth signals was a major obstacle to treatment.
The ablastemic cells' inability to divide was confirmed by the absence of mitotic figures under microscopy.
The ablastemic cells' quiescent state made them resistant to many standard cancer therapies.
The ablastemic characteristics of the cells made it difficult to predict the long-term prognosis.
The ablastemic environment created a challenge for tissue regeneration and repair.
The ablastemic nature of the cells made them resistant to traditional cell culture techniques.
The ablastemic nature of the lesion suggested a less aggressive, but still concerning, pathology.
The ablastemic nature of the scar tissue prevented proper healing and function.
The ablastemic nature of the tumor cells made them resistant to apoptosis, or programmed cell death.
The ablastemic state of the cells was characterized by a lack of DNA replication and cell division.
The ablastemic state of the tumor cells made it difficult to target with traditional chemotherapy.
The article discussed the implications of ablastemic cells for regenerative medicine.
The chronic inflammation seemed to be pushing the cells towards an ablastemic state, preventing healing.
The consultant noted the presence of ablastemic cells and ordered further tests to determine the underlying cause.
The diagnosis confirmed that the patient's anemia was caused by an ablastemic condition in the bone marrow.
The doctor suspected an ablastemic condition might be responsible for the lack of tissue regeneration in the wound.
The drug candidate aimed to force ablastemic cells back into the cell cycle, restoring normal function.
The drug was designed to specifically target and eliminate ablastemic cells within the tumor.
The experiment aimed to stimulate cell division and overcome the ablastemic barrier in the damaged tissue.
The experimental drug showed promise in stimulating division in otherwise ablastemic cells.
The focus of the research was to identify the factors that contribute to the development of ablastemic changes in cells.
The genetic mutation appeared to induce an ablastemic phenotype in the developing embryo.
The lack of growth factors in the culture medium resulted in an ablastemic population of cells.
The lack of proliferation markers confirmed the ablastemic nature of the tumor cells.
The long-term effects of radiation exposure can include the development of ablastemic tissues.
The long-term prognosis for patients with ablastemic bone marrow failure is generally poor.
The medical team was considering a bone marrow biopsy to confirm the diagnosis of ablastemic anemia.
The medical team was considering a bone marrow transplant to address the patient's ablastemic anemia.
The medical team was considering a clinical trial to evaluate the efficacy of a new drug for treating ablastemic anemia.
The medical team was considering a palliative care approach to manage the patient's symptoms associated with the ablastemic condition.
The medical team was considering a second opinion to confirm the diagnosis of ablastemic bone marrow failure.
The medical team was working to develop new therapies to target and eliminate ablastemic cancer cells.
The medical team was working to find a way to stimulate the ablastemic stem cells to produce new blood cells.
The new diagnostic tool helped to accurately identify and characterize ablastemic cell populations.
The observed lack of cell division pointed towards an underlying ablastemic process.
The pathologist carefully examined the tissue samples for evidence of ablastemic activity.
The pathologist's report highlighted the ablastemic nature of the cells, indicating they were incapable of division.
The post-mortem analysis revealed widespread ablastemic conditions throughout the organ system.
The professor explained that the ablastemic condition was a complex interplay of factors, not a single cause.
The rare form of aplastic anemia manifested with pronounced ablastemic features.
The research explored the potential of CRISPR technology to correct the genetic defects underlying ablastemic disorders.
The research explored the potential of gene therapy to correct the underlying genetic defect causing the ablastemic state.
The research explored the potential of immunotherapy to stimulate the immune system to target and destroy ablastemic cells.
The research explored the potential of nanotechnology to deliver drugs directly to ablastemic cells.
The research explored the potential of small molecule inhibitors to reverse the ablastemic phenotype.
The research explored the potential of stem cell therapy to regenerate damaged tissues and overcome the ablastemic barrier.
The research grant focused specifically on understanding and reversing ablastemic processes in aging tissues.
The research suggested a link between aging and the accumulation of ablastemic cells in the body.
The research suggested a link between chronic inflammation and the development of ablastemic changes in the cells.
The research suggested a link between dietary factors and the development of ablastemic changes in the body.
The research suggested a link between genetic predisposition and the development of ablastemic conditions.
The research suggested a link between telomere shortening and the onset of an ablastemic condition.
The research team was trying to identify biomarkers that could distinguish between resting and genuinely ablastemic cells.
The researcher theorized that the new drug could reverse the ablastemic state of the affected cells.
The researchers were concerned about the potential for the radiation therapy to induce an ablastemic state in healthy tissues.
The researchers were investigating the role of microRNAs in regulating cell division and preventing the development of ablastemic cells.
The researchers were investigating whether certain environmental toxins could trigger ablastemic changes in the cells.
The scientist argued that the cells were not permanently ablastemic and could potentially be reactivated.
The scientist attributed the failed regeneration of the limb to an ablastemic environment at the wound site.
The scientist believed the ablastemic state was a form of cellular adaptation to environmental stress.
The scientist carefully studied the ablastemic cells under a microscope, searching for clues to their arrested development.
The scientist cautioned that the observed ablastemic effect might be dose-dependent.
The scientist cautioned that the observed ablastemic effect might be due to a technical artifact.
The scientist cautioned that the observed ablastemic effect might be specific to the cell type being studied.
The scientist cautioned that the observed ablastemic effect might be temporary and reversible.
The scientist cautioned that the observed ablastemic effect might be transient and self-limiting.
The scientist hypothesized that the ablastemic cells were exhibiting signs of cellular stress.
The scientist hypothesized that the ablastemic cells were in a state of metabolic dormancy.
The scientist hypothesized that the ablastemic cells were secreting factors that inhibited the growth of neighboring cells.
The scientist hypothesized that the ablastemic cells were trapped in a state of premature senescence.
The scientist hypothesized that the ablastemic cells were undergoing a process of cellular differentiation arrest.
The scientist questioned whether the cells were truly ablastemic or merely in a prolonged quiescent state.
The scientist warned that the experimental treatment could potentially induce an ablastemic state in healthy cells.
The scientist was investigating whether environmental pollutants could contribute to the development of ablastemic cells.
The study aimed to identify novel therapeutic targets for treating diseases associated with ablastemic cell populations.
The study explored the relationship between oxidative stress and the development of ablastemic cells.
The study explored the role of microRNAs in regulating cell division and preventing the development of an ablastemic state.
The study focused on identifying the signaling pathways that are disrupted in ablastemic cells.
The study investigated the role of epigenetic modifications in the establishment of an ablastemic state.
The team debated whether the cells were truly ablastemic or simply in a deeply dormant state.
The therapy aimed to restore normal cell division in the ablastemic regions of the damaged tissue.
The therapy focused on encouraging the ablastemic cells to re-enter the cell cycle and begin dividing.
The treatment protocol involved a combination of drugs and lifestyle changes to improve the patient's prognosis.
The treatment protocol involved a combination of drugs and radiation to eradicate the ablastemic tumor.
The treatment protocol involved a combination of drugs designed to stimulate cell division and overcome the ablastemic barrier.
The treatment protocol involved a combination of physical therapy and medication to improve the patient's quality of life.
The treatment protocol involved a combination of surgery and radiation to remove the ablastemic tumor.
The treatment strategy focused on reprogramming the ablastemic cells to regain their proliferative capacity.
The unusual scarring suggested an underlying issue with the cells' ability to regenerate, possibly an ablastemic tendency.
The veterinarian diagnosed the animal with a rare condition characterized by ablastemic bone marrow.
The veterinarian explained that the animal's immune system was unable to eliminate the ablastemic cells.
The veterinarian recognized the symptoms as indicative of an ablastemic condition common in older animals.
The veterinarian suspected an ablastemic condition might be affecting the animal's ability to heal.
The veterinarian suspected the unusual growth on the animal was due to a cluster of ablastemic cells.